Cerebral glycogenolysis and stimulation of beta-adrenoreceptors and histamine H2 receptors.
D000818:Animals; D000831:Animals, Newborn; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002645:Chickens; D000242:Cyclic AMP / Q000096:biosynthesis; D005260:Female; D006003:Glycogen / Q000378:metabolism*; D006632:Histamine / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008785:Metiamide / Q000494:pharmacology; D006005:Phosphorylases / Q000378:metabolism; D011433:Propranolol / Q000494:pharmacology; D011941:Receptors, Adrenergic
D006634:Histamine H1 Antagonists; D011941:Receptors, Adrenergic; D008785:Metiamide; D006632:Histamine; D006003:Glycogen; D011433:Propranolol; D000242:Cyclic AMP; D006005:Phosphorylases; D007545:Isoproterenol